company background image
6833 logo

Sinco Pharmaceuticals Holdings SEHK:6833 주식 보고서

최종 가격

HK$0.17

시가총액

HK$337.5m

7D

-24.2%

1Y

-33.6%

업데이트

04 Nov, 2024

데이터

회사 재무

Sinco Pharmaceuticals Holdings Limited

SEHK:6833 주식 보고서

시가총액: HK$337.5m

6833 주식 개요

투자 지주회사인 신코 파마슈티컬스 홀딩스는 중국에서 수입 의약품 및 의료기기에 대한 마케팅, 프로모션, 채널 관리 서비스를 제공합니다.

6833 기본 분석
눈송이 점수
가치 평가2/6
미래 성장0/6
과거 실적4/6
재무 상태5/6
배당금1/6

Sinco Pharmaceuticals Holdings Limited 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Sinco Pharmaceuticals Holdings
과거 주가
현재 주가HK$0.17
52주 최고치HK$0.32
52주 최저치HK$0.16
베타0.88
11개월 변경-39.64%
3개월 변경 사항-31.97%
1년 변경 사항-33.60%
33년 변화-84.04%
5년 변화-51.88%
IPO 이후 변화-79.25%

최근 뉴스 및 업데이트

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Recent updates

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

주주 수익률

6833HK HealthcareHK 마켓
7D-24.2%-1.5%-1.0%
1Y-33.6%-23.5%15.0%

수익률 대 산업: 6833 underperformed the Hong Kong Healthcare industry which returned -23.5% over the past year.

수익률 대 시장: 6833 underperformed the Hong Kong Market which returned 15% over the past year.

가격 변동성

Is 6833's price volatile compared to industry and market?
6833 volatility
6833 Average Weekly Movement8.9%
Healthcare Industry Average Movement8.4%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.3%

안정적인 주가: 6833 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

시간에 따른 변동성: 6833's weekly volatility (9%) has been stable over the past year.

회사 소개

설립직원CEO웹사이트
2011303Min Jinwww.sinco-pharm.com

투자 지주회사인 신코 파마슈티컬스 홀딩스는 중국에서 수입 의약품 및 의료기기에 대한 마케팅, 홍보, 채널 관리 서비스를 제공합니다. 미숙아에 사용하는 인간 알부민 용액인 옥타파마, 호흡기 감염, 요로 감염, 연조직 감염, 부인과 및 산과 감염, 임질 및 기타 감염을 포함한 박테리아 감염 치료와 수술 후 감염 예방에 사용되는 악세틴, 수술 후 감염 예방에 사용되는 메도세프 등을 공급하고 있습니다; 폐렴, 요로, 담관, 복막, 피부, 연조직, 골반 부위 및 패혈증과 같은 세균성 감염 치료에 사용되는 메도세프. 또한 저인산혈증 및 알코올 중독, 영양실조, 저인산혈증성 호흡부전 등 만성질환 치료에 사용되는 에사포스피나, 담석 질환 치료에 사용되는 경구용 콜산제제 타우로라이트, 전이성 전립선암, 진성 성조숙증, 자궁내막증 치료제 타미필 주사제 등을 공급하고 있습니다.

Sinco Pharmaceuticals Holdings Limited 기본 사항 요약

Sinco Pharmaceuticals Holdings 의 수익과 매출은 시가총액과 어떻게 비교하나요?
6833 기본 통계
시가총액HK$337.46m
수익(TTM)HK$51.10m
수익(TTM)HK$3.26b

6.6x

P/E 비율

0.1x

P/S 비율

6833 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
6833 손익 계산서(TTM)
수익CN¥2.98b
수익 비용CN¥2.63b
총 이익CN¥343.95m
기타 비용CN¥297.32m
수익CN¥46.63m

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)0.023
총 마진11.55%
순이익 마진1.57%
부채/자본 비율50.8%

6833 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

2.3%

현재 배당 수익률

15%

지급 비율